Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.7 USD | +1.28% | +0.78% | -8.42% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
MarketScreener Editorial Features
MarketScreener's World Press Review: January 10 | January 10, 2023 at 08:39 am EST | |
An unusual period for stock markets | July 07, 2022 at 09:43 am EDT | |
ANALYST RECOMMENDATIONS : Bunge, Coinbase, Ford, Morgan Stanley, Goldman Sachs... | July 07, 2022 at 05:38 am EDT |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- MarketScreener Editorial Features